SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059757
Filing Date
2023-11-07
Accepted
2023-11-07 07:06:34
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itos-20230930.htm   iXBRL 10-Q 2818166
2 EX-31.1 itos-ex31_1.htm EX-31.1 17787
3 EX-31.2 itos-ex31_2.htm EX-31.2 17791
4 EX-32.1 itos-ex32_1.htm EX-32.1 18870
  Complete submission text file 0000950170-23-059757.txt   10074282

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itos-20230930_def.xml EX-101.DEF 216630
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itos-20230930_pre.xml EX-101.PRE 352609
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itos-20230930.xsd EX-101.SCH 58414
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itos-20230930_cal.xml EX-101.CAL 48919
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itos-20230930_lab.xml EX-101.LAB 465436
65 EXTRACTED XBRL INSTANCE DOCUMENT itos-20230930_htm.xml XML 1927058
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39401 | Film No.: 231381518
SIC: 2836 Biological Products, (No Diagnostic Substances)